Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men

Clinical and Experimental Immunology

Volumn 175, Issue 3, 2014, Pages 468-475

  Lisulo, M M ^a   Kapulu, M C ^a   Banda, R ^a   Sinkala, E ^a   Kayamba, V ^a   Sianongo, S ^a   Kelly, P ^a,b  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

IgA; Oral vaccines; Retinoic acid; Retinoid pharmacokinetics; Typhoid vaccine

Indexed keywords

ALITRETINOIN; CHOLERA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ISOTRETINOIN; LIPOPOLYSACCHARIDE; RETINOIC ACID; RETINOID; RETINOL PALMITATE; TY 21A; TYPHOID VACCINE; UNCLASSIFIED DRUG; VESA;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; HUMAN; IN VITRO STUDY; LAVAGE; LOW DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; MIDDLE AGED; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TYPHOID FEVER; WHOLE GUT LAVAGE FLUID; YOUNG ADULT; ZAMBIA;

IGA; ORAL VACCINES; RETINOIC ACID; RETINOID PHARMACOKINETICS; TYPHOID VACCINE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADULT; ANTIBODIES, BACTERIAL; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; TRETINOIN; TYPHOID-PARATYPHOID VACCINES; YOUNG ADULT; ZAMBIA;

EID: 84893349534     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12238     Document Type: Article

References (43)

1. Petri WA, Miller M, Binder HJ etal. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest 2008; 118:1277-1290.
2. Checkley W, Epstein LD, Gilman RH, Cabrera L, Black RE. Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol 2003; 157:166-175.
3. Grimwood K, Lambert SB, Milne RJ. Rotavirus infections and vaccines. Pediatr Drugs 2010; 12:235-256.
4. Pasetti MF, Simon JK, Sztein MB, Levine MM. Immunology of gut mucosal vaccines. Immunol Rev 2011; 239:125-148.
5. Vesikari T, Matson DO, Dennehy P etal. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl J Med 2006; 354:23-33.
6. Zaman K, Dang DA, Victor JC etal. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-623.
7. Vesikari T, Karvonen A, Prymula R etal. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis in the first two years of life in European infants: randomised double-blind controlled study. Lancet 2007; 370:1757-1763.
8. Mahdi SA, Cunliffe NA, Steele D etal. Effect of human rotavirus vaccine on severe diarrhea in African infants. New Engl J Med 2010; 362:289-298.
9. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012; 12:592-605.
10. Germain P, Chambon P, Eichele G etal. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 2006; 58:712-725.
11. Tang X-H, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol-Mech 2011; 6:345-364.
12. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004; 328:1-16.
13. Iwata M, Hirakiyama A, Eshima Y etal. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527-538.
14. Takenouchi-Ohkubo N, Asano M, Chihaya H etal. Retinoic acid enhances the gene expression of human polymeric immunoglobulin receptor (pIgR) by TNF-alpha. Clin Exp Immunol 2004; 135:448-454.
15. Coombes JL, Coombes JL, Siddiqui KR etal. A functionally specialised population of mucosal CD103+ DCs induces Foxp3 regulatory T cells via a TGFβ and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757-1764.
16. Golovina TN, Mikheeva T, Brusko TM etal. Retinoic acid and rifamycins differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLOS ONE 2011; 6:e15868.
17. Wang C, Kang SG, Hogen Esch H, Love PE, Kim CH. Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine. J Immunol 2010; 184:5519-5526.
18. Villablanca E, Wang S, DeCalisto J etal. MyD88 and retinoic acid signaling pathways interact to modulate gastrointestinal activities of dendritic cells. Gastroenterology 2011; 141:176-185. epub before print.
19. Cassani B, Villablanca EJ, Quintana FJ etal. Gut tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral tolerance in mice. Gastroenterology 2011; 141:2109-2118.
20. Hammerschmidt SI, Friedrischsen M, Boelter J etal. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J Clin Invest 2011; 121:3051-3061.
21. Tan X, Sande JL, Pufnock JS, Blattman JN, Greenberg PD. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J Virol 2011; 85:8316-8327.
22. Sanz MA, Lo-Coco F. Modern approaches to treating acute promyelocytic leukaemia. J Clin Oncol 2011; 29:495-503.
23. Rogers JE, Yang D. Differentiation syndrome in patients with acute promyelocytic leukemia. J Oncol Pharm Pract 2011; 18:109-114. epub ahead of print.
24. Takitani K, Koh M, Inoue A, Kawakami C, Kuno T, Tamai H. Pharmacokinetics of all-trans retinoic acid in adults and children with acute promyelocytic leukemia. Am J Hematol 2006; 81:720-721.
25. Adams J. The neurobehavioral teratology of retinoids: a 50-year history. Birth Defects Res (Part A) 2010; 88:895-905.
26. Hartmann S, Brors O, Bock J etal. Exposure to retinyl esters, retinol, and retinoic acids in non-pregnant women following increasing single and repeated doses of vitamin A. Ann Nutr Metab 2005; 49:155-164.
27. Kapulu MC, Simuyandi M, Sianongo S etal. Differential changes in expression of intestinal antimicrobial peptide genes during Ascaris lumbricoides infection in Zambian adults do not respond to helminth eradication. J Infect Dis 2011; 203:1464-1473.
28. Kelly P, Menzies I, Crane R etal. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 2004; 70:412-419.
29. Ozpolat B, Lopez-Berestein G, Adamson P, Fu CJ, Williams AH. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J Pharm Pharm Sci 2003; 6:292-301.
30. Lanvers C, Reinhardt D, Dubbers A etal. Pharmacology of all-trans retinoic acid in children with acute promyelocytic leukemia. Med Pediatr Oncol 2003; 40:293-301.
31. McNamara PJ, Jewell RC, Jensen BK, Brindley CJ. Food increases the bioavailability of acitretin. J Clin Pharmacol 1988; 28:1051-1055.
32. Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret J-F. Experience with registered mucosal vaccines. Vaccine 2003; 21:678-683.
33. Lucas MES, Deen JL, von Seidlein L, Wang X-Y, Ampuero J etal. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. New Engl J Med 2005; 352:757-767.
34. Daley AC, Randall R, Darsley M etal. Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation. Gut 2007; 56:1550-1556.
35. Luderitz O, Risse HJ, Schulte-Holthausen H etal. Biochemical studies of the smooth-rough mutation in Salmonella minnesota. J Bacteriol 1965; 89:343-354.
36. Pulendram B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006; 124:849-863.
37. Prendergast A, Kelly P. Enteropathies in the developing world; neglected effects on global health. Am J Trop Med Hyg 2012; 86:756-763.
38. Harrison EH. Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin carotenoids. Biochim Biophys Acta 2012; 1821:70-77.
39. D'Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients 2011; 3:61-103.
40. Savy M, Edmond K, Fine PE etal. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr 2009; 139:2154S-2218.
41. Benn CS. Combining vitamin A and vaccines: convenience or conflict? Dan Med J 2012; 59:B4378.
42. Kim HN, Harrington RD, Crane HM, Dhanireddy S, Dellit TH, Spach DH. Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations. Int J STD AIDS 2009; 20:595-600.
43. Wilkin T, Lee JY, Lensing SY etal. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis 2010; 15:1246-1253.